Quick Takeaways
- Anthony S. Gibney has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,672,060.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Anthony S. Gibney
- Location
- New Haven, CT
- Summary
- The estimated net worth of Anthony S. Gibney is at least $1,672,060 dollars as of 18 Mar 2026. Anthony S. Gibney is the Chief Financial and Business Officer of Aura Biosciences, Inc. and owns shares of Aura Biosciences, Inc. (AURA) stock worth about $1.53M. Anthony S. Gibney is the Director of Clearside Biomedical, Inc. and owns shares of Clearside Biomedical, Inc. (CLSDQ) stock worth about $130K. Anthony S. Gibney is the Director of InflaRx N.V. and owns shares of InflaRx N.V. (IFRX) stock worth about $9.3K.
- Signature
- /s/ Christian Schmid, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anthony S. Gibney and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Aura Biosciences, Inc. ($1,532,760).
- Past-year value change for that position: +$237,177.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Anthony S. Gibney
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | Chief Financial and Business Officer | $1,532,760 | +$237,177 | +18% | 02 Mar 2026 |
| CLSDQ | Clearside Biomedical, Inc. | Director | $130,000 | 20 Jun 2024 | ||
| IFRX | InflaRx N.V. | Director | $9,300 | 18 Mar 2026 | ||
| ISEE | IVERIC bio, Inc. | EVP, Chief Business Officer | 11 Jul 2023 |
Insider Transactions Reported by Anthony S. Gibney:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.